Clinical Trials Browser

Interventional × Metastatic Hormone Refractory Prostate Cancer × Clear all

NCT04477512 2025-11-12

Cabozantinib and Abiraterone With Checkpoint Inhibitor Immunotherapy in Metastatic Hormone Sensitive Prostate Cancer (CABIOS Trial)

Phase 1 Completed

Metastatic Hormone Refractory Prostate Cancer

NCT00766324 2014-05-28

PHA-739358 for Treatment of Hormone Refractory Prostate Cancer

Phase 2 Completed

Metastatic Hormone Refractory Prostate Cancer